Fibromyalgia severity according to age categories: results of a cross-sectional study from a large national database.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 16 06 2021
accepted: 20 09 2021
pubmed: 7 4 2022
medline: 29 6 2022
entrez: 6 4 2022
Statut: ppublish

Résumé

The role of age in influencing the severity of fibromyalgia (FM) is still controversial. The aim of this study is to define the contribution of age in the severity of FM from data from a large national database. This cross-sectional study included adult patients with FM diagnosed according to the 2010/2011 American College of Rheumatology criteria. Disease severity was assessed with the revised Fibromyalgia Impact Questionnaire (FIQR) and the modified Fibromyalgia Assessment Status (FAS 2019mod). Patients were grouped into five age categories (between 18-40 years, between 41-50 years, between 51-60 years, between 61-70 years, and ≥71 years). Differences in disease severity between groups were assessed by one-way analysis of variance (ANOVA). The study included 2889 patients (199 males and 2690 females), mean age of 52.58 (±11.82) years, with a mean FIQR score of 59.22 (±22.98) and a mean FAS 2019mod of 25.50 (±8.66). Comparing the mean values of the various indices between age categories, there were no statistically significant differences between the groups for FIQR total score and FAS 2019mod. However, the 60-70 years category showed the lowest scores for both scales. The main difference emerged for the FIQR physical function subscale, where the ≥71 years category showed significantly higher scores (p<0.05) compared the 18-40 years category. The severity of FM has a significant level of stationarity according to age categories. Patients between 60-70 years have a lower disease burden. Physical function is the health domain with the most significant difference between the groups.

Identifiants

pubmed: 35383567
pii: 17554
doi: 10.55563/clinexprheumatol/od40pa
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1084-1090

Auteurs

Marco Di Carlo (M)

Rheumatology Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Ancona, Italy. dica.marco@yahoo.it.

Sonia Farah (S)

Rheumatology Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Ancona, Italy.

Laura Bazzichi (L)

Rheumatology Unit, AOU Pisana, Pisa, Italy.

Fabiola Atzeni (F)

Rheumatology Unit, Department of Internal Medicine, University of Messina, Italy.

Marcello Govoni (M)

Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna di Ferrara, Italy.

Giovanni Biasi (G)

Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy.

Manuela Di Franco (M)

Department of Internal Medicine, Anesthesiological and Cardiovascular Sciences, Rheumatology Unit, Policlinico Umberto I, Sapienza University of Rome, Italy.

Flavio Mozzani (F)

Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-Universitaria di Parma, Italy.

Elisa Gremese (E)

Rheumatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Lorenzo Dagna (L)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Alberto Batticciotto (A)

Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Ospedale Di Circolo, Fondazione Macchi, Varese, Italy.

Fabio Fischetti (F)

Unit of Rheumatology, ASUGI and Clinical University Department of Medical, Surgery and Health Sciences, University of Trieste, Italy.

Roberto Giacomelli (R)

University of Rome "Campus Biomedico", School of Medicine, Division of Rheumatology and Clinical Immunology, Roma, Italy.

Serena Guiducci (S)

Department of Experimental and Clinical Medicine, Divisions of Rheumatology AOUC, University of Florence, Italy.

Giuliana Guggino (G)

Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Italy.

Mario Bentivegna (M)

Integrated Reference Centre of Rheumatology, ASP 7, Scicli Hospital, Ragusa, Italy.

Roberto Gerli (R)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Carlo Salvarani (C)

University of Modena and Reggio Emilia, Azienda USL-IRCCS di Reggio Emilia, Italy.

Gianluigi Bajocchi (G)

Rheumatology Unit, S. Maria Hospital, USL, IRCCS Institute, Reggio Emilia, Italy.

Marco Ghini (M)

Rheumatology Unit, Azienda USL di Modena, Italy.

Florenzo Iannone (F)

Rheumatology Unit, Department of Emergency and Organ Transplantations, University of Bari, Italy.

Valeria Giorgi (V)

Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan, Italy.

Mariateresa Cirillo (M)

Rheumatology Unit, Department of Internal Medicine, University of Messina, Italy.

Sara Bonazza (S)

Rheumatology, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria S. Anna di Ferrara, Italy.

Stefano Barbagli (S)

Rheumatology Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Italy.

Chiara Gioia (C)

Department of Internal Medicine, Anesthesiological and Cardiovascular Sciences, Rheumatology Unit, Policlinico Umberto I, Sapienza University of Rome, Italy.

Noemi Giuliana Marino (NG)

Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-Universitaria di Parma, Italy.

Annunziata Capacci (A)

Rheumatology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Giulio Cavalli (G)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Antonella Cappelli (A)

Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Ospedale Di Circolo, Fondazione Macchi, Varese, Italy.

Francesco Carubbi (F)

Clinical Unit of Rheumatology, School of Medicine, University of L'Aquila, Italy.

Francesca Nacci (F)

Department of Experimental and Clinical Medicine, Divisions of Rheumatology AOUC, University of Florence, Italy.

Ilenia Riccucci (I)

Rheumatology Unit, Department of Medicine and Surgery, University of Perugia, Italy.

Maurizio Cutolo (M)

Research Laboratory and Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino, Genova, Italy.

Luigi Sinigaglia (L)

Division of Rheumatology, ASST Gaetano Pini-CTO, Milano, Italy.

Piercarlo Sarzi-Puttini (P)

Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan University School of Medicine, Milan, Italy.

Fausto Salaffi (F)

Rheumatology Clinic, Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Jesi, Ancona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH